Patent application number | Description | Published |
20100048481 | Controlled Release Composition - The invention relates to the field of pharmacology. More specific, the invention relates to a controlled release composition. | 02-25-2010 |
20100062531 | RGD Containing Recombinant Gelatin - The invention concerns recombinant gelatins with unevenly distributed RGD motifs that are of particular use in several applications involving cell attachment such as in cell culture work and applications involving cell cultures of anchor dependent cells and also in a variety of medical applications. | 03-11-2010 |
20100075902 | Recombinant XRGD-Enriched Gelatins Having High Stability - The invention concerns recombinant gelatin monomers and recombinant gelatins comprising or consisting of multimers of the monomers. The recombinant gelatins are of particular use in several applications involving cell attachment such as in cell culture work and applications involving cell cultures of anchor dependent cells and also in a variety of medical applications. | 03-25-2010 |
20100105618 | Non-Natural Recombinant Gelatins with Enhanced Functionality - The invention concerns recombinant gelatin monomers and recombinant gelatins comprising or consisting of multimers of the monomers. The recombinant gelatins can be produced with enhanced stability. | 04-29-2010 |
20100119574 | Recombinant Gelatins - The invention concerns a recombinant CBE gelatin and recombinant gelatins having multimers of the CBE monomer sequence that are of particular use in several applications involving cell attachment such as in cell culture work and applications involving cell cultures of anchor dependent cells and also in a variety of medical applications. | 05-13-2010 |
20100203138 | Controlled Release Composition Comprising a Recombinant Gelatin - The invention relates to the field of pharmacology. More specific, the invention relates to a controlled release composition. In one of the embodiments, the invention provides a method for preparing a controlled release composition comprising the steps of:
| 08-12-2010 |
20100273215 | Secretion Yield of a Protein of Interest by in vivo Proteolytic Processing of a Multimeric Precursor - The invention relates to a nucleic acid molecule encoding a multimeric precursor which after transcription is specifically cleaved in vivo to form multiple copies of a protein of interest. The invention further relates to a cell comprising this nucleic acid molecule and a method for producing a protein of interest using this cell. | 10-28-2010 |
20110106243 | Coating Method for Medical Devices - The invention relates to a method for coating medical devices with a biocompatible protein coating. | 05-05-2011 |
20110256222 | Recombinant Protein Enriched in a Heparin Binding Site and/or in a Heparan Sulfate Binding Site - The invention relates to a recombinant protein enriched in a heparin binding site and/or a heparan sulfate binding site. Such recombinant protein is used as an in vivo controlled release system of a protein of interest. | 10-20-2011 |
20120107372 | RECOMBINANT GELATINS - The invention concerns a recombinant CBE gelatin and recombinant gelatins having multimers of the CBEmonomersequence that are of particular use in several applications involving cell attachment such as in cell culture work and applications involving cell cultures of anchor dependent cells and also in a variety of medical applications. | 05-03-2012 |
20130157956 | BIOCOMPATIBLE COMPOSITIONS FOR TISSUE AUGMENTATION - A crosslinked gelatin hydrogel composition for tissue augmentation. | 06-20-2013 |
20130273606 | SECRETION YIELD OF A PROTEIN OF INTEREST BY IN VIVO PROTEOLYTIC PROCESSING OF A MULTIMERIC PRECURSOR - The invention relates to a nucleic acid molecule encoding a multimeric precursor which after transcription is specifically cleaved in vivo to form multiple copies of a protein of interest. The invention further relates to a cell comprising this nucleic acid molecule and a method for producing a protein of interest using this cell. | 10-17-2013 |